DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0019100 | Severe Dengue | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0015310 | Exotropia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0004153 | Atherosclerosis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0028738 | Nystagmus | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0030312 | Pancytopenia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1852438 | CATARACT, COPPOCK-LIKE | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C3463824 | MYELODYSPLASTIC SYNDROME | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0025517 | Metabolic Diseases | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0566602 | Primary sclerosing cholangitis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C3714636 | Pneumonitis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0005745 | Blepharoptosis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1956346 | Coronary Artery Disease | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0027726 | Nephrotic Syndrome | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0019187 | Hepatitis, Alcoholic | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0948008 | Ischemic stroke | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0015652 | Fascioliasis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C3887494 | ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1168401 | Squamous cell carcinoma of the head and neck | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1565489 | Renal Insufficiency | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0027404 | Narcolepsy | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0019189 | Hepatitis, Chronic | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0011265 | Presenile dementia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0162557 | Liver Failure, Acute | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1306459 | Primary malignant neoplasm | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1859726 | ARTERIAL TORTUOSITY SYNDROME | SLC2A10 | 81031 | solute carrier family 2 member 10 | O95528 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024